The role of Federal legislation on breast cancer disparities
联邦立法对乳腺癌差异的作用
基本信息
- 批准号:8374988
- 负责人:
- 金额:$ 16.53万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-12-14 至 2013-11-30
- 项目状态:已结题
- 来源:
- 关键词:AccountingAddressAdverse effectsAfrican AmericanAgeAreaBehavioralBiologicalCaringCenters of Research ExcellenceCessation of lifeCharacteristicsComorbidityDataDeveloped CountriesDiagnosisDiseaseDrug PrescriptionsElderlyElderly womanEpidemiologyEthnic OriginHIVHealthHealth InsuranceHealthcareHighly Active Antiretroviral TherapyIndividualInterventionLawsLicensingLifeLife ExpectancyLinkLogistic RegressionsMammographyMeasuresMedicalMedical AssistanceMedicareMedicare claimModelingModificationNational Cancer InstituteNational Center on Minority Health and Health DisparitiesNaturePatientsPersonsPoliciesPolicy MakerPositioning AttributeProviderRaceRelative (related person)Research PersonnelResourcesRespiratory distressRoleSafetySamplingScreening procedureServicesSocioeconomic StatusSolutionsSourceStatutes and LawsTestingTimeTranslatingUnited States Centers for Medicare and Medicaid ServicesUnited States Food and Drug AdministrationWomanabstractingbasecancer health disparitycancer information systemdrug marketfallshazardhealth disparityhuman very old age (85+)innovationlow socioeconomic statusmalignant breast neoplasmmortalityolder womenprematureprogramspsychologicsocialsocioeconomicssuccesssurfactant
项目摘要
4.2.12. Levine Abstract. The role of federal legislation on breast cancer disparities After the Medicare program began to reimburse providers for screening mammography, mortality from breast cancer among US elderly began to fall. However, rates fell more rapidly among whites, and racial disparities widened. Interestingly, disparities did not widen uniformly across the US. We hypothesize that Medicare law inadvertently favors acquisition of screening mammography services by whites since it defines medical assistance as a cash benefit to pay providers regardless of the extent to which cash is the primary barrier to service acquisition. We propose to use the observed geographic variability in mortality disparities to address this hypothesis. We shall obtain large national samples of Medicare data and SEER-linked Medicare claims data to test the following sub-hypotheses: H-l: Regional and state level characteristics will have a significant effect on mammography utilization after adjusting for individual factors. H-2: The effect of regional and state level characteristics on mammography utilization will be different for African American and White women. H-3: The region having the greatest equitability for screening mammography utilization will be more likely to have programs in place aiming to increase mammography utilization and reduce disparities. H-4: Relative to places with moderate to high levels of success, failing places will be more likely to have low survival from breast cancer, and greater percentage increase in racial disparity in survival over time. H-5: Relative to places that are failing or have moderate to high screening mammography
utilization, exceptionally successful places will be more likely to have high survival from breast cancer, and to have greater percentage reduction in racial disparity in survival over time. We believe there are compelling reasons to address the proposed hypotheses using alternative means as soon as possible: (a) thousands of deaths from breast cancer among the elderly may have
already occurred or will occur because of unintended, adverse effects traceable to Medicare's definition of medical assistance as cash to pay providers; (b) breast cancer may be the tip of the iceberg, particularly with the advent of new programs to provide cash for prescription drugs as part of Medicare; and (c) there may be wider implications as regards the observed declines[2] in US position relative to other industrialized nations for life expectancy and other key measures. The project also proposes reasonable means for obtaining preliminary answers that will be useful for policy makers.
4.2.12.摘要:联邦立法对乳腺癌差异的作用在医疗保险计划开始报销提供者的乳房X光检查后,美国老年人乳腺癌的死亡率开始下降。然而,白人的比率下降得更快,种族差距扩大。有趣的是,美国各地的差距并没有均匀扩大。我们假设,医疗保险法无意中有利于白人获得筛查乳房X光检查服务,因为它将医疗援助定义为向提供者支付的现金福利,而不管现金在多大程度上是获得服务的主要障碍。我们建议使用观察到的死亡率差异的地理变异性来解决这一假设。 我们将获得医疗保险数据和与SEER相关的医疗保险索赔数据的大的国家样本,以测试以下子假设:H-1:在针对个体因素进行调整后,区域和州水平的特征将对乳房X射线摄影术的利用具有显著影响。 H-2:对于非裔美国人和白色女性,区域和州一级特征对乳腺X射线摄影利用率的影响不同。H-3:在乳房X线检查使用方面最公平的地区更有可能制定旨在提高乳房X线检查使用率和减少差异的方案。H-4:相对于那些成功率从中等到高的地方,失败的地方更有可能患乳腺癌的生存率很低,随着时间的推移,生存率的种族差异会增加更大的百分比。H-5:相对于失败或有中度到高度筛查乳腺X线摄影的地方
利用率,特别成功的地方将更有可能从乳腺癌中获得高生存率,并且随着时间的推移,生存率的种族差异将有更大的减少。我们相信有令人信服的理由尽快使用替代方法来解决所提出的假设:(a)数千名老年人死于乳腺癌可能是由于
已经发生或将要发生,因为意外的,不良影响可追溯到医疗保险的医疗援助的定义为现金支付提供者;(B)乳腺癌可能是冰山一角,特别是随着新的计划的出现,为处方药提供现金作为医疗保险的一部分;(c)美国在预期寿命和其他关键指标方面相对于其他工业化国家的地位下降可能会产生更广泛的影响。 该项目还提出了获得对决策者有用的初步答案的合理手段。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ROBERT A LEVINE其他文献
ROBERT A LEVINE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ROBERT A LEVINE', 18)}}的其他基金
The role of Federal legislation on breast cancer disparities
联邦立法对乳腺癌差异的作用
- 批准号:
7685244 - 财政年份:2009
- 资助金额:
$ 16.53万 - 项目类别:
Conference on Complementary and Alternative Medicine
补充和替代医学会议
- 批准号:
7095601 - 财政年份:2005
- 资助金额:
$ 16.53万 - 项目类别:
Effect of Mitral Regurgitation on Ischemic LV Remodeling
二尖瓣反流对缺血性左室重构的影响
- 批准号:
7784799 - 财政年份:2003
- 资助金额:
$ 16.53万 - 项目类别:
Effect of Mitral Regurgitation on Ischemic LV Remodeling
二尖瓣反流对缺血性左室重构的影响
- 批准号:
8420189 - 财政年份:2003
- 资助金额:
$ 16.53万 - 项目类别:
Effect of Mitral Regurgitation on Ischemic LV Remodeling
二尖瓣反流对缺血性左室重构的影响
- 批准号:
8197425 - 财政年份:2003
- 资助金额:
$ 16.53万 - 项目类别:
Effect of Mitral Regurgitation on Ischemic LV Remodeling
二尖瓣反流对缺血性左室重构的影响
- 批准号:
7093175 - 财政年份:2003
- 资助金额:
$ 16.53万 - 项目类别:
Effect of Mitral Regurgitation on Ischemic LV Remodeling
二尖瓣反流对缺血性左室重构的影响
- 批准号:
6862312 - 财政年份:2003
- 资助金额:
$ 16.53万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 16.53万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 16.53万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 16.53万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 16.53万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 16.53万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 16.53万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 16.53万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 16.53万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 16.53万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 16.53万 - 项目类别:
Research Grant














{{item.name}}会员




